Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesUse of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial
BMC Musculoskeletal Disorders, 06/23/09
Claessen SJJ et al. - First rheumatological study for treatment in early arthritis based on a prediction rule where treatment will be stratified according to the probability of persistent arthritis has entered the clinical trial. Different combinations of treatment per stratum will be evaluated; treatment will start early, and patients will not need to meet the ACR-criteria for rheumatoid arthritis.
Methods- Randomized trial is currently being performed to determine which induction therapy is most effective in the very early stage of persistent arthritis
- Induction therapy will be based on a prediction model that predicts pts' propensity for persistent arthritis
- Pts ≥18 yrs with recent-onset arthritis (n=810) are being stratified according to the likelihood of their developing persistent arthritis
- Following therapies are planned:
- Pts with a high probability persistent arthritis: combination of DMARDs vs monotherapy MTX
- Pts with an intermediate probability of persistent arthritis: DMARDs of various intensities
- Pts with a low probability: NSAIDs, hydroxychloroquine and a single dose of corticosteroids
- If disease activity is not sufficiently reduced, treatment will be adjusted according to a step-up protocol
- If remission is achieved for at least 6 mo, medication will be tapered off
- Pts will be followed up every 3 mo over 2 yrs
- The trial is being conducted in the southwestern Netherlands, and the results are awaited
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Annals of Rheumatic Diseases, 10/12/09
The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial
Annals of Rheumatic Diseases, 10/23/09
Sponsor
Article Search
Sponsor